Among the most characterized lncRNAs associated with cancer development and drug resistance are H19 (42), X-inactive-specific transcript (XIST) (43), and homeobox (HOX) transcript antisense RNA (HOTAIR) (44). This evidence concerns the gene H19 and cancer.